Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 2C7H5O3.Zn |
| Molecular Weight | 339.635 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Zn++].OC1=CC=CC=C1C([O-])=O.OC2=CC=CC=C2C([O-])=O
InChI
InChIKey=PZXFWBWBWODQCS-UHFFFAOYSA-L
InChI=1S/2C7H6O3.Zn/c2*8-6-4-2-1-3-5(6)7(9)10;/h2*1-4,8H,(H,9,10);/q;;+2/p-2
| Molecular Formula | C7H5O3 |
| Molecular Weight | 137.1128 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Zn |
| Molecular Weight | 65.409 |
| Charge | 2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The application of bioactive compounds from the food industry to control mold growth in indoor waterborne coatings. | 2013-04-01 |
|
| Oral administration of Bis(aspirinato)zinc(II) complex ameliorates hyperglycemia and metabolic syndrome-like disorders in spontaneously diabetic KK-A(y) mice: structure-activity relationship on zinc-salicylate complexes. | 2011 |
|
| An evaluation of retrograde tracing methods for the identification of chemically distinct cochlear efferent neurons. | 1990-07 |
|
| Extraction and determination of zinc in pharmaceutical samples. | 1989-04 |
Patents
Sample Use Guides
Mice were treated with Zn(sal)2 at the dose of 15 mg Zn/kg body weight for 24 d by daily oral administrations.
Zinc salicylate is a component of cosmetic products for acne-prone skin applying once or twice a day.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21804241
Zn(sal)2 exerts insulinomimetic activity in the free fatty acids release from isolated rat adipocytes (IC50 1 mM)
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:34:02 GMT 2025
by
admin
on
Mon Mar 31 19:34:02 GMT 2025
|
| Record UNII |
96OQ2F972S
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
96OQ2F972S
Created by
admin on Mon Mar 31 19:34:02 GMT 2025 , Edited by admin on Mon Mar 31 19:34:02 GMT 2025
|
PRIMARY | |||
|
240-380-7
Created by
admin on Mon Mar 31 19:34:02 GMT 2025 , Edited by admin on Mon Mar 31 19:34:02 GMT 2025
|
PRIMARY | |||
|
m11625
Created by
admin on Mon Mar 31 19:34:02 GMT 2025 , Edited by admin on Mon Mar 31 19:34:02 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB35402
Created by
admin on Mon Mar 31 19:34:02 GMT 2025 , Edited by admin on Mon Mar 31 19:34:02 GMT 2025
|
PRIMARY | |||
|
100000128394
Created by
admin on Mon Mar 31 19:34:02 GMT 2025 , Edited by admin on Mon Mar 31 19:34:02 GMT 2025
|
PRIMARY | |||
|
DTXSID6048624
Created by
admin on Mon Mar 31 19:34:02 GMT 2025 , Edited by admin on Mon Mar 31 19:34:02 GMT 2025
|
PRIMARY | |||
|
16283-36-6
Created by
admin on Mon Mar 31 19:34:02 GMT 2025 , Edited by admin on Mon Mar 31 19:34:02 GMT 2025
|
PRIMARY | |||
|
54693468
Created by
admin on Mon Mar 31 19:34:02 GMT 2025 , Edited by admin on Mon Mar 31 19:34:02 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
|
PARENT -> SALT/SOLVATE |